We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

LadRx Corp (LADX) USD0.001

Sell:$2.52 Buy:$2.52 Change: No change
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Sell:$2.52
Buy:$2.52
Change: No change
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Sell:$2.52
Buy:$2.52
Change: No change
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LadRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company focuses on the discovery, research and clinical development of anti-cancer drug candidates that employ technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The Company’s linker activated drug release (LADR) technology platform consists of an organic backbone that is attached to a chemo toxic agent. The LADR backbone is to first target and deliver the chemo toxic agent to the tumor environment, and then to release the chemo toxic agent within the tumor. The LADR Technology offers the opportunity for multiple pipeline drugs. The LADR development efforts are focused on two classes of ultra-high potency albumin-binding drugs. These LADR-based drugs, LADRs 7, 8, 9, and 10, combine the proprietary LADR backbone with derivatives of the auristatin and maytansinoid drug classes.

Contact details

Address:
11726 San Vicente Boulevard, Suite 650
LOS ANGELES
90049
United States
Telephone:
+1 (310) 8265648
Website:
https://www.ladrxcorp.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LADX
ISIN:
US2328287071
Market cap:
$1.25 million
Shares in issue:
495,092
Sector:
Biotechnology
Exchange:
Off Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Stephen Snowdy
    Chief Executive Officer
  • John Caloz
    Chief Financial Officer, Senior Vice President, Treasurer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.